Edwards Lifesciences shows prevailing Real Value of $114.89 per share. The current price of the firm is $112.03. At this time the firm appears to be fairly valued. Macroaxis computes value of Edwards Lifesciences from reviewing the firm fundamentals such as Shares Outstanding of 211.16M, Profit Margin of
22.16% and Current Valuation of 22.97B as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
Valuation Drivers Correlation
|Investment Horizon||30 Days Login to change|
Edwards Lifesciences Corporation is rated # 5 in price to earning category among related companies. It is rated below average in beta category among related companies totaling about 0.02 of Beta per Price to Earning. The ratio of Price to Earning to Beta for Edwards Lifesciences Corporation is roughly 43.24
Edwards Lifesciences is not too risky asset. Calculation of real value of Edwards Lifesciences is based on 1 month time horizon. Increasing Edwards Lifesciences time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.